Wide-Field Optical Redox Imaging with Leading-Edge Detection Enables Assessment of Treatment Response and Heterogeneity in Patient-Derived Cancer Organoids

Researchers assessed and predicted patient-derived cancer organoid response to treatments based on mutational profiles using label-free wide-field optical redox imaging.